Old Web
English
Sign In
Acemap
>
authorDetail
>
Mark C. Wilkinson
Mark C. Wilkinson
Liverpool School of Tropical Medicine
Snake venom
Biology
Pharmacology
Viper Venoms
Echis
4
Papers
39
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Anticoagulant Activity of Naja nigricollis Venom Is Mediated by Phospholipase A2 Toxins and Inhibited by Varespladib.
2021
Toxins
Taline D. Kazandjian
Arif Arrahman
Kristina B. M. Still
Govert W. Somsen
Freek J. Vonk
Nicholas R. Casewell
Mark C. Wilkinson
Jeroen Kool
Show All
Source
Cite
Save
Citations (1)
Preclinical validation of a repurposed metal chelator as an early-intervention therapeutic for hemotoxic snakebite.
2020
Science Translational Medicine
Laura-Oana Albulescu
Melissa S. Hale
Stuart Ainsworth
Jaffer Alsolaiss
Edouard Crittenden
Juan J. Calvete
Chloe Evans
Mark C. Wilkinson
Robert A. Harrison
Jeroen Kool
Nicholas R. Casewell
Show All
Source
Cite
Save
Citations (31)
Cross-species and geographic potential of B-cell epitope strings identified for generation of an Africa-specific snake venom-induced necrosis therapeutic.
2020
Toxicon
Charlotte A. Dawson
Stuart Ainsworth
Mark C. Wilkinson
Robert A. Harrison
Show All
Source
Cite
Save
Citations (0)
Preclinical validation of a repurposed metal chelator as a community-based therapeutic for hemotoxic snakebite
2019
bioRxiv
Laura-Oana Albulescu
Melissa S. Hale
Stuart Ainsworth
Jaffer Alsolaiss
Edouard Crittenden
Juan J. Calvete
Mark C. Wilkinson
Robert A. Harrison
Jeroen Kool
Nicholas R. Casewell
Show All
Source
Cite
Save
Citations (7)
1